1. Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study. Issue 10306 (25th September 2021) Authors: Hutchings, Martin; Mous, Rogier; Clausen, Michael Roost; Johnson, Peter; Linton, Kim M; Chamuleau, Martine E D; Lewis, David John; Sureda Balari, Anna; Cunningham, David; Oliveri, Roberto S; Elliott, Brian; DeMarco, Dena; Azaryan, Ada; Chiu, Christopher; Li, Tommy; Chen, Kuo-mei; Ahmadi, Tahamtan... Journal: Lancet Issue: Volume 398:Issue 10306(2021) Page Start: 1157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗